Brain chemical dopamine may hold key to preventing falls in seniors
NCT ID NCT06587217
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at whether the brain chemical dopamine helps older adults maintain fast walking speed despite age-related changes. Five participants aged 60 and older with mild parkinsonian signs took carbidopa and carbidopa-levodopa for 10 days. Researchers measured walking speed using sensors to see if boosting dopamine improves mobility.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Carbidopa and carbidopa-levodopa (Sinemet)
- What this could lead to
- If successful, this could point toward a treatment to improve walking and reduce fall risk in older adults with mild parkinsonian signs.
- What could go wrong
- This is a very small, early-phase study with only 5 participants, so results may not apply to the general population. The drugs used can cause side effects like nausea or dizziness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PARKINSONIAN SIGNS IN OLDER PERSONS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Domino's Farms
Ann Arbor, Michigan, 48105, United States
-
University Hospital
Ann Arbor, Michigan, 48109, United States